Skip to main content
. 2020 Dec 14;15:10183–10197. doi: 10.2147/IJN.S282931

Figure 8.

Figure 8

Pharmacokinetics and biodistribution. (A) Pharmacokinetics of PDA NPs and PDA@SCM NPs over a span of 24 h. (B) Representative ex vivo image showing biodistributions of PDA NPs and PDA@SCMs NPs in major organs and tumor tissues from each group 24 h after intravenous injection of PDA and PDA@SCM. (C) In vivo study the biological distribution of PDA NPs and PDA@SCM NPs quantitatively in major organs and tumor tissues at 24 h after intravenous injection. *p < 0.05, **p < 0.01, ***p < 0.001.